Patient Persistence to OnabotulinumtoxinA Treatment for Overactive Bladder Using a Reduced Injection‐Site Paradigm: A Retrospective Chart Review Study

Documenti analoghi

• Optimizing the Injection Schema for Higher Doses of OnabotulinumtoxinA (BTX‐A) in the Office Setting: A Randomized Prospective Trial for Patients With Neurogenic Lower Urinary Tract Dysfunction and Idiopathic Overactive Bladder
  di: Annie Chen, et al.
  Pubblicazione: (2025)
• Association Between Urodynamic Findings and Urinary Retention After Onabotulinumtoxin A for Idiopathic Overactive Bladder
  di: Anjali Kapur, et al.
  Pubblicazione: (2025)
• A Systematic Review and Meta‐Analysis on the Prevalence and Risk Factors of Overactive Bladder in Diabetic Patients
  di: Xiaolong Zhang, et al.
  Pubblicazione: (2026)
• Can Baseline Urodynamic Findings Predict the Outcomes and Complications of Intravesical Injections of Onabotulinum Toxin A for Overactive Bladder?
  di: Kristina Aleksejeva, et al.
  Pubblicazione: (2025)
• The Role of Urinary ATP in the Diagnosis, Treatment, and Follow‐up of Children With Overactive Bladder
  di: Turker Altuntas, et al.
  Pubblicazione: (2025)